Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Abbott, Alere Agree To Mediation For Troubled Merger

Executive Summary

Abbott announced plans to purchase Alere in January, but the merger has so far been delayed by, Alere alleges, Abbott's foot-dragging. Abbott, meanwhile, points to federal investigations that have delayed Alere’s financial filings.


Related Content

January Court Date Set for Abbott, Alere Merger
J&J Buys Abbott's Ophthalmics Business For $4bn-Plus
Alere Sues To Compel Completion Of Abbott Merger
Alere Hit With Another Federal Subpoena, Casting More Doubt On Abbott Deal
The Rumors Were True: Abbott Buys St. Jude For $25b To Create Third Cardiovascular Giant


Related Companies